SequelSEC

WEST PHARMACEUTICAL SERVICES INC WST

Surgical & Medical Instruments & Apparatus · CIK 0000105770 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$3.33B
Fiscal year ended 2026-06-30
Operating income
$680.40M
Fiscal year ended 2026-06-30
Free cash flow
$436.90M
Fiscal year ended 2026-06-30

WEST PHARMACEUTICAL SERVICES INC (WST) reported revenue of $3.33B and net income of $564.90M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from WEST PHARMACEUTICAL SERVICES INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

WEST PHARMACEUTICAL SERVICES INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$3.33B
Cost of revenue$2.10B
Gross profit$1.22B
Operating income$680.40M
Net income$564.90M
Research & development$74.40M
Weighted-average diluted sharesUnavailable
Pretax income$693.60M
Income tax expense$144.20M
Diluted EPSUnavailable
Selling, general & administrative$426.80M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

WEST PHARMACEUTICAL SERVICES INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$435.80M
Total assets$4.08B
Current assets$1.81B
Total liabilities$1.09B
Current liabilities$640.50M
Total equity incl. NCI$2.99B
Temporary (mezzanine) equityUnavailable
Inventory$447.40M
Accounts receivable$712.00M
Goodwill$108.70M
Long-term debt$202.90M
Accounts payable$252.70M

Cash flow

WEST PHARMACEUTICAL SERVICES INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$662.20M
Capital expenditures$225.30M
Investing cash flow-$225.30M
Financing cash flow-$496.70M
Net change in cash-$73.90M
Stock-based compensation$32.60M
Common dividends paid$62.40M
Common share repurchases$454.30M
Depreciation & amortization$181.40M

Derived

WEST PHARMACEUTICAL SERVICES INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$436.90M
Gross margin36.8%
Operating margin20.5%
FCF margin13.1%
SBC / revenue1.0%
Current ratio2.82x
Revenue YoY growth12.4%
Net margin17.0%
R&D / revenue2.2%
CapEx / revenue6.8%
Long-term debt / equity0.07x
Effective tax rate20.8%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open WST in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-23View SEC filing
10-Q · Filed 2026-04-23View SEC filing
10-K · Filed 2026-02-17View SEC filing
10-Q · Filed 2025-10-23View SEC filing
10-Q · Filed 2025-07-24View SEC filing
10-Q · Filed 2025-04-24View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.